EANM procedure guidelines for treatment of refractory metastatic bone pain
- PMID: 12723557
- DOI: 10.1007/s00259-002-1057-1
EANM procedure guidelines for treatment of refractory metastatic bone pain
Similar articles
-
EANM procedure guidelines for radiosynovectomy.Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):BP12-6. doi: 10.1007/s00259-002-1058-0. Eur J Nucl Med Mol Imaging. 2003. PMID: 12723558 No abstract available.
-
Pain palliation and nuclear medicine.Eur J Nucl Med. 1993 Jan;20(1):1-3. doi: 10.1007/BF02261237. Eur J Nucl Med. 1993. PMID: 7678395 No abstract available.
-
Targeted radionuclide therapy for bone metastases.Eur J Nucl Med. 1993 Jan;20(1):66-74. doi: 10.1007/BF02261248. Eur J Nucl Med. 1993. PMID: 7678397 Review.
-
Re-186 HEDP treatment in breast cancer patients with bone metastases.J Natl Med Assoc. 2008 Apr;100(4):447. doi: 10.1016/s0027-9684(15)31281-5. J Natl Med Assoc. 2008. PMID: 18481487 No abstract available.
-
186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases.Q J Nucl Med. 2001 Mar;45(1):84-90. Q J Nucl Med. 2001. PMID: 11456380 Review.
Cited by
-
Personalized Radiation Therapy in Cancer Pain Management.Cancers (Basel). 2019 Mar 19;11(3):390. doi: 10.3390/cancers11030390. Cancers (Basel). 2019. PMID: 30893954 Free PMC article. Review.
-
Concurrent use of Sr-89 chloride with zoledronic acid is safe and effective for breast cancer patients with painful bone metastases.Exp Ther Med. 2012 Feb;3(2):226-230. doi: 10.3892/etm.2011.405. Epub 2011 Dec 2. Exp Ther Med. 2012. PMID: 22969873 Free PMC article.
-
Added value of hybrid SPECT with CT imaging for predicting poor therapeutic efficacy of 89Sr in patients with bone metastasis.Sci Rep. 2020 Dec 3;10(1):21207. doi: 10.1038/s41598-020-78372-5. Sci Rep. 2020. PMID: 33273651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical